Inside informationEnglish
BIOPHYTIS and a Consortium of Investors including RONGHUI RENHE Life Technology Join Forces to Finance and Launch First-Ever Phase 3 Trial in Sarcopenia
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- Biophytis
- Filed
- 13/10/2025, 06:59
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 079921_20251013